Biom’up granted FDA IDE approval for HEMOSNOWTM

Ergomed’s PrimeVigilance awarded 2019 Queen’s Award for Enterprise

CENTOGENE Appoints AI Industry Leader Dr. Carsten Ullrich as Director of Artificial Intelligence

Atriva Therapeutics wishes you happy Easter!

CEVEC closes major financing round to further expand and commercialize its viral vector manufacturing platform

Motif Bio Presents New Iclaprim Data at ECCMID 2019

Adocia announces first quarter 2019 financial results: cash position and revenue

Motif Bio reports fiscal year 2018 results

Biom’up announces first US sales in laparoscopy for HEMOBLASTTM Bellows and the signing of an exclusive distribution agreement for HEMOBLASTTM Bellows in Australia

Probiodrug raises EUR 8.2 million from investors in successful private placement of new shares